PRO TALK RECAP

Wed, July 17 2024
thumbnail
CNBC Pro Talks: From weight loss drugs to AI winners, CIO set to reveal his top stocks

More in Pro Talks

watch now
VIDEO42:57
CNBC Pro Talks: From weight loss drugs to AI winners, CIO reveals his top stocks
Weight loss drugs and artificial intelligence have been dominating headlines, with investors betting that stocks in both categories have big potential upside. CNBC’s Senior Technology Correspondent Arjun Kharpal spoke to Tema ETFs’ Yuri Khodjamirian on how to best invest in these areas.
watch now
VIDEO49:16
CNBC Pro Talks: Fund manager reveals how to invest after India’s election
CNBC’s Tanvir Gill spoke to Causeway Capital Management’s Arjun Jayaraman on how to navigate the Indian markets following the national election, as well as investing in other emerging markets.
watch now
VIDEO01:04:27
Pro Talks: Jim Lebenthal on the fundamental analysis tools that will make you a better investor
Veteran "Halftime" guest and investor Jim Lebenthal sat down with CNBC's Dominic Chu to discuss how the former nuclear engineer and U.S. Navy officer created a science-minded approach to fundamental analysis and value investing that has led to a decades-long career on Wall Street.
watch now
VIDEO36:03
CNBC Pro Talks: Beyond Nvidia: Outperforming fund manager reveals the top AI stocks to buy
Clare Pleydell-Bouverie, who co-manages Liontrust Asset Management’s global tech, innovation and dividend funds, revealed her favorite ways to play the themes of artificial intelligence, Big Tech and more.
watch now
VIDEO01:09:43
Pro Talks: How to profit from Warren Buffett's methods in investing and life
How can investors use the timeless investing strategies and sage teachings of the iconic Warren Buffett to make their own investing decisions? What does the portfolio of Berkshire-owned companies and stocks say about your own portfolio? CNBC Pro goes on a deep dive into all things Buffett with a longtime Berkshire shareholder and follower.
About

CNBC Pro Talks are live discussions designed to give subscribers exclusive access to CNBC talent and the biggest names in investing. Subscribers can also submit questions to guests